Delaware biopharma company secures $95 million in funding
AdvertisementPrelude Therapeutics, a privately held, clinical-stage biopharmaceutical company secured $60 million in Series B financing. Investments to date total $95 million. The company is headed by a founder of Wilmington-based … Continue reading Delaware biopharma company secures $95 million in funding
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed